Insightful, real information. Thanks for your time, effort, and sharing. There is true information on your website.

I still think Gene has the highest probability for good news and upside, and the least risk; when compared to lipid or vra. We know Factive is going on sale and there is a sales force being hired. Ramoplanin is in fast track phase 3 and it is for Clostridium difficile-associated diarrhea which occurs commonly to patients in hospitals. Patients commonly get this bacteria while in the hospital for surgery or heart problems or any other problem unreleated to diarrhea. Hospitals are embarrased and diarrhea can be deadly for patients. Currently there is nothing on the market to cure it quickly. That is why Ramoplanin got fast track.

We know that a day like today is actually good. A pull back is okay on low volume.